These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
357 related articles for article (PubMed ID: 16569668)
1. Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex. Judge LM; Haraguchiln M; Chamberlain JS J Cell Sci; 2006 Apr; 119(Pt 8):1537-46. PubMed ID: 16569668 [TBL] [Abstract][Full Text] [Related]
2. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins. Tidball JG; Wehling-Henricks M Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129 [TBL] [Abstract][Full Text] [Related]
3. Restoration of all dystrophin protein interactions by functional domains in trans does not rescue dystrophy. Gardner KL; Kearney JA; Edwards JD; Rafael-Fortney JA Gene Ther; 2006 May; 13(9):744-51. PubMed ID: 16307000 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice. Chakkalakal JV; Harrison MA; Carbonetto S; Chin E; Michel RN; Jasmin BJ Hum Mol Genet; 2004 Feb; 13(4):379-88. PubMed ID: 14681302 [TBL] [Abstract][Full Text] [Related]
5. A highly functional mini-dystrophin/GFP fusion gene for cell and gene therapy studies of Duchenne muscular dystrophy. Li S; Kimura E; Ng R; Fall BM; Meuse L; Reyes M; Faulkner JA; Chamberlain JS Hum Mol Genet; 2006 May; 15(10):1610-22. PubMed ID: 16595609 [TBL] [Abstract][Full Text] [Related]
6. Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. Rooney JE; Welser JV; Dechert MA; Flintoff-Dye NL; Kaufman SJ; Burkin DJ J Cell Sci; 2006 Jun; 119(Pt 11):2185-95. PubMed ID: 16684813 [TBL] [Abstract][Full Text] [Related]
7. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298 [TBL] [Abstract][Full Text] [Related]
8. Dystrophin and utrophin: genetic analyses of their role in skeletal muscle. Rafael JA; Brown SC Microsc Res Tech; 2000 Feb 1-15; 48(3-4):155-66. PubMed ID: 10679963 [TBL] [Abstract][Full Text] [Related]
9. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423 [TBL] [Abstract][Full Text] [Related]
10. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy. Cox GA; Sunada Y; Campbell KP; Chamberlain JS Nat Genet; 1994 Dec; 8(4):333-9. PubMed ID: 7894482 [TBL] [Abstract][Full Text] [Related]
12. Absence of alpha 7 integrin in dystrophin-deficient mice causes a myopathy similar to Duchenne muscular dystrophy. Guo C; Willem M; Werner A; Raivich G; Emerson M; Neyses L; Mayer U Hum Mol Genet; 2006 Mar; 15(6):989-98. PubMed ID: 16476707 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405 [TBL] [Abstract][Full Text] [Related]
14. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Lapidos KA; Kakkar R; McNally EM Circ Res; 2004 Apr; 94(8):1023-31. PubMed ID: 15117830 [TBL] [Abstract][Full Text] [Related]
15. Absence of neuronal nitric oxide synthase (nNOS) as a pathological marker for the diagnosis of Becker muscular dystrophy with rod domain deletions. Torelli S; Brown SC; Jimenez-Mallebrera C; Feng L; Muntoni F; Sewry CA Neuropathol Appl Neurobiol; 2004 Oct; 30(5):540-5. PubMed ID: 15488030 [TBL] [Abstract][Full Text] [Related]
16. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice. Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118 [TBL] [Abstract][Full Text] [Related]
17. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice. Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842 [TBL] [Abstract][Full Text] [Related]
18. Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle. Tanihata J; Suzuki N; Miyagoe-Suzuki Y; Imaizumi K; Takeda S J Gene Med; 2008 Jun; 10(6):702-13. PubMed ID: 18338831 [TBL] [Abstract][Full Text] [Related]
19. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice. Gillis JM Acta Neurol Belg; 2000 Sep; 100(3):146-50. PubMed ID: 11098286 [TBL] [Abstract][Full Text] [Related]
20. CAPON expression in skeletal muscle is regulated by position, repair, NOS activity, and dystrophy. Ségalat L; Grisoni K; Archer J; Vargas C; Bertrand A; Anderson JE Exp Cell Res; 2005 Jan; 302(2):170-9. PubMed ID: 15561099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]